These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. Henke PK; Blackburn S; Proctor MC; Stevens J; Mukherjee D; Rajagopalin S; Upchurch GR; Stanley JC; Eagle KA J Vasc Surg; 2004 Feb; 39(2):357-65. PubMed ID: 14743136 [TBL] [Abstract][Full Text] [Related]
4. Impact of inflow reconstruction on infrainguinal bypass. Eagleton MJ; Illig KA; Green RM; Ouriel K; Riggs PN; DeWeese JA J Vasc Surg; 1997 Dec; 26(6):928-36; discussion 937-8. PubMed ID: 9423707 [TBL] [Abstract][Full Text] [Related]
5. Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk. Arvela E; Venermo M; Söderström M; Albäck A; Lepäntalo M Ann Vasc Surg; 2012 Apr; 26(3):396-403. PubMed ID: 22285375 [TBL] [Abstract][Full Text] [Related]
6. Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. Sarac TP; Huber TS; Back MR; Ozaki CK; Carlton LM; Flynn TC; Seeger JM J Vasc Surg; 1998 Sep; 28(3):446-57. PubMed ID: 9737454 [TBL] [Abstract][Full Text] [Related]
7. Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia. Arvela E; Söderström M; Albäck A; Aho PS; Venermo M; Lepäntalo M J Vasc Surg; 2010 Sep; 52(3):616-23. PubMed ID: 20615645 [TBL] [Abstract][Full Text] [Related]
8. Comparison of precuffed expanded polytetrafluorothylene and heparin-bonded polytetrafluorothylene graft in crural bypass. Bellosta R; Natalini G; Luzzani L; Carugati C; Sarcina A Ann Vasc Surg; 2013 Feb; 27(2):218-24. PubMed ID: 23092735 [TBL] [Abstract][Full Text] [Related]
15. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease. Donker JM; Ho GH; Te Slaa A; de Groot HG; van der Waal JC; Veen EJ; van der Laan L Vasc Endovascular Surg; 2011 Oct; 45(7):598-603. PubMed ID: 21757494 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of last autogenous option arm vein bypass. Robinson DR; Varcoe RL; Chee W; Subramaniam PS; Benveniste GL; Fitridge RA ANZ J Surg; 2013 Oct; 83(10):769-73. PubMed ID: 23464494 [TBL] [Abstract][Full Text] [Related]
17. Autogenous arterial bypass grafts: durable patency and limb salvage in patients with inframalleolar occlusive disease and end-stage renal disease. Treiman GS; Lawrence PF; Rockwell WB J Vasc Surg; 2000 Jul; 32(1):13-22. PubMed ID: 10876202 [TBL] [Abstract][Full Text] [Related]
18. Arm vein as a last autogenous option for infrainguinal bypass surgery: it is worth the effort. Varcoe RL; Chee W; Subramaniam P; Roach DM; Benveniste GL; Fitridge RA Eur J Vasc Endovasc Surg; 2007 Jun; 33(6):737-41. PubMed ID: 17293130 [TBL] [Abstract][Full Text] [Related]
19. A comparison of femorocrural bypasses performed with modified heparin-bonded expanded polytetrafluorethylene grafts and those with great saphenous vein grafts to treat critical limb ischemia. Gessaroli M; Tarantini S; Leone M; Fabbri E; Panzini I Ann Vasc Surg; 2015 Aug; 29(6):1255-64. PubMed ID: 26025478 [TBL] [Abstract][Full Text] [Related]
20. The influence of graft type on patency of infrainguinal arterial bypass grafts. Neale ML; Graham JC; Lane RJ; Cheung DS; Appleberg M J Am Coll Surg; 1994 Feb; 178(2):155-63. PubMed ID: 8173726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]